Copyright Reports & Markets. All rights reserved.

Global Peanut Allergy Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Peanut Allergy Therapeutics by Type
    • 1.3.1 Overview: Global Peanut Allergy Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Peanut Allergy Therapeutics Consumption Value Market Share by Type in 2023
    • 1.3.3 Epinephrine Injection
    • 1.3.4 Antihistamines
    • 1.3.5 Oral Immunotherapy
    • 1.3.6 Other
  • 1.4 Global Peanut Allergy Therapeutics Market by Distribution Channel
    • 1.4.1 Overview: Global Peanut Allergy Therapeutics Market Size by Distribution Channel: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacy
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Peanut Allergy Therapeutics Market Size & Forecast
  • 1.6 Global Peanut Allergy Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global Peanut Allergy Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Peanut Allergy Therapeutics Market Size by Region, (2019-2030)
    • 1.6.3 North America Peanut Allergy Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Peanut Allergy Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Peanut Allergy Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Peanut Allergy Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Peanut Allergy Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Mylan
    • 2.1.1 Mylan Details
    • 2.1.2 Mylan Major Business
    • 2.1.3 Mylan Peanut Allergy Therapeutics Product and Solutions
    • 2.1.4 Mylan Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Mylan Recent Developments and Future Plans
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Peanut Allergy Therapeutics Product and Solutions
    • 2.2.4 Bayer Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bayer Recent Developments and Future Plans
  • 2.3 UCB Pharma
    • 2.3.1 UCB Pharma Details
    • 2.3.2 UCB Pharma Major Business
    • 2.3.3 UCB Pharma Peanut Allergy Therapeutics Product and Solutions
    • 2.3.4 UCB Pharma Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 UCB Pharma Recent Developments and Future Plans
  • 2.4 J & J
    • 2.4.1 J & J Details
    • 2.4.2 J & J Major Business
    • 2.4.3 J & J Peanut Allergy Therapeutics Product and Solutions
    • 2.4.4 J & J Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 J & J Recent Developments and Future Plans
  • 2.5 Perrigo
    • 2.5.1 Perrigo Details
    • 2.5.2 Perrigo Major Business
    • 2.5.3 Perrigo Peanut Allergy Therapeutics Product and Solutions
    • 2.5.4 Perrigo Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Perrigo Recent Developments and Future Plans
  • 2.6 GSK
    • 2.6.1 GSK Details
    • 2.6.2 GSK Major Business
    • 2.6.3 GSK Peanut Allergy Therapeutics Product and Solutions
    • 2.6.4 GSK Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 GSK Recent Developments and Future Plans
  • 2.7 Kaleo
    • 2.7.1 Kaleo Details
    • 2.7.2 Kaleo Major Business
    • 2.7.3 Kaleo Peanut Allergy Therapeutics Product and Solutions
    • 2.7.4 Kaleo Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Kaleo Recent Developments and Future Plans
  • 2.8 Amneal Pharma
    • 2.8.1 Amneal Pharma Details
    • 2.8.2 Amneal Pharma Major Business
    • 2.8.3 Amneal Pharma Peanut Allergy Therapeutics Product and Solutions
    • 2.8.4 Amneal Pharma Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Amneal Pharma Recent Developments and Future Plans
  • 2.9 ALK Abello
    • 2.9.1 ALK Abello Details
    • 2.9.2 ALK Abello Major Business
    • 2.9.3 ALK Abello Peanut Allergy Therapeutics Product and Solutions
    • 2.9.4 ALK Abello Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 ALK Abello Recent Developments and Future Plans
  • 2.10 Aimmune Therapeutics
    • 2.10.1 Aimmune Therapeutics Details
    • 2.10.2 Aimmune Therapeutics Major Business
    • 2.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Product and Solutions
    • 2.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Aimmune Therapeutics Recent Developments and Future Plans
  • 2.11 HUAPONT Pharm
    • 2.11.1 HUAPONT Pharm Details
    • 2.11.2 HUAPONT Pharm Major Business
    • 2.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Product and Solutions
    • 2.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 HUAPONT Pharm Recent Developments and Future Plans
  • 2.12 Allergy Therapeutics
    • 2.12.1 Allergy Therapeutics Details
    • 2.12.2 Allergy Therapeutics Major Business
    • 2.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Product and Solutions
    • 2.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Allergy Therapeutics Recent Developments and Future Plans
  • 2.13 ASIT Biotech
    • 2.13.1 ASIT Biotech Details
    • 2.13.2 ASIT Biotech Major Business
    • 2.13.3 ASIT Biotech Peanut Allergy Therapeutics Product and Solutions
    • 2.13.4 ASIT Biotech Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 ASIT Biotech Recent Developments and Future Plans
  • 2.14 Sanofi
    • 2.14.1 Sanofi Details
    • 2.14.2 Sanofi Major Business
    • 2.14.3 Sanofi Peanut Allergy Therapeutics Product and Solutions
    • 2.14.4 Sanofi Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Sanofi Recent Developments and Future Plans
  • 2.15 DBV Technologies
    • 2.15.1 DBV Technologies Details
    • 2.15.2 DBV Technologies Major Business
    • 2.15.3 DBV Technologies Peanut Allergy Therapeutics Product and Solutions
    • 2.15.4 DBV Technologies Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 DBV Technologies Recent Developments and Future Plans
  • 2.16 HAL Allergy
    • 2.16.1 HAL Allergy Details
    • 2.16.2 HAL Allergy Major Business
    • 2.16.3 HAL Allergy Peanut Allergy Therapeutics Product and Solutions
    • 2.16.4 HAL Allergy Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 HAL Allergy Recent Developments and Future Plans
  • 2.17 Intrommune Therapeutics
    • 2.17.1 Intrommune Therapeutics Details
    • 2.17.2 Intrommune Therapeutics Major Business
    • 2.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Product and Solutions
    • 2.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Intrommune Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Peanut Allergy Therapeutics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Peanut Allergy Therapeutics by Company Revenue
    • 3.2.2 Top 3 Peanut Allergy Therapeutics Players Market Share in 2023
    • 3.2.3 Top 6 Peanut Allergy Therapeutics Players Market Share in 2023
  • 3.3 Peanut Allergy Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 Peanut Allergy Therapeutics Market: Region Footprint
    • 3.3.2 Peanut Allergy Therapeutics Market: Company Product Type Footprint
    • 3.3.3 Peanut Allergy Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Peanut Allergy Therapeutics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Peanut Allergy Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Distribution Channel

  • 5.1 Global Peanut Allergy Therapeutics Consumption Value Market Share by Distribution Channel (2019-2024)
  • 5.2 Global Peanut Allergy Therapeutics Market Forecast by Distribution Channel (2025-2030)

6 North America

  • 6.1 North America Peanut Allergy Therapeutics Consumption Value by Type (2019-2030)
  • 6.2 North America Peanut Allergy Therapeutics Market Size by Distribution Channel (2019-2030)
  • 6.3 North America Peanut Allergy Therapeutics Market Size by Country
    • 6.3.1 North America Peanut Allergy Therapeutics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Peanut Allergy Therapeutics Consumption Value by Type (2019-2030)
  • 7.2 Europe Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2019-2030)
  • 7.3 Europe Peanut Allergy Therapeutics Market Size by Country
    • 7.3.1 Europe Peanut Allergy Therapeutics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.3 France Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2019-2030)
  • 8.3 Asia-Pacific Peanut Allergy Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Region (2019-2030)
    • 8.3.2 China Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.5 India Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Peanut Allergy Therapeutics Consumption Value by Type (2019-2030)
  • 9.2 South America Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2019-2030)
  • 9.3 South America Peanut Allergy Therapeutics Market Size by Country
    • 9.3.1 South America Peanut Allergy Therapeutics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2019-2030)
  • 10.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Peanut Allergy Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Peanut Allergy Therapeutics Market Drivers
  • 11.2 Peanut Allergy Therapeutics Market Restraints
  • 11.3 Peanut Allergy Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Peanut Allergy Therapeutics Industry Chain
  • 12.2 Peanut Allergy Therapeutics Upstream Analysis
  • 12.3 Peanut Allergy Therapeutics Midstream Analysis
  • 12.4 Peanut Allergy Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
    According to our (Global Info Research) latest study, the global Peanut Allergy Therapeutics market size was valued at US$ 981 million in 2023 and is forecast to a readjusted size of USD 8492 million by 2030 with a CAGR of 36.5% during review period.
    United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.
    Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.
    This report is a detailed and comprehensive analysis for global Peanut Allergy Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Peanut Allergy Therapeutics market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Peanut Allergy Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Peanut Allergy Therapeutics market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), 2019-2030
    Global Peanut Allergy Therapeutics market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Peanut Allergy Therapeutics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Peanut Allergy Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan, Bayer, UCB Pharma, J & J, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Peanut Allergy Therapeutics market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Peanut Allergy Therapeutics market is split by Type and by Distribution Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Epinephrine Injection
    Antihistamines
    Oral Immunotherapy
    Other
    Market segment by Distribution Channel
    Hospital Pharmacy
    Retail Pharmacy
    Other
    Market segment by players, this report covers
    Mylan
    Bayer
    UCB Pharma
    J & J
    Perrigo
    GSK
    Kaleo
    Amneal Pharma
    ALK Abello
    Aimmune Therapeutics
    HUAPONT Pharm
    Allergy Therapeutics
    ASIT Biotech
    Sanofi
    DBV Technologies
    HAL Allergy
    Intrommune Therapeutics
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Peanut Allergy Therapeutics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Peanut Allergy Therapeutics, with revenue, gross margin, and global market share of Peanut Allergy Therapeutics from 2019 to 2024.
    Chapter 3, the Peanut Allergy Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Distribution Channel, with consumption value and growth rate by Type, by Distribution Channel, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Peanut Allergy Therapeutics market forecast, by regions, by Type and by Distribution Channel, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Peanut Allergy Therapeutics.
    Chapter 13, to describe Peanut Allergy Therapeutics research findings and conclusion.

    Buy now